Welcome to the e-CCO Library!

search
Search by: 
Year: Category: Sub Type:
OP004: Resetting of the mucosal T cell repertoire after hematopoietic stem cell transplantation in refractory Crohn‘s Disease
Year: 2017
Source: ECCO'17 Barcelona
Authors: Allez M.
Last Modified: Wednesday, 15 March 2017, 1:48 PM by ECCO Administrator
Autologous stem cell transplantation, T cell
Files: 1
OP005: The PROSIT cohort of infliximab biosimilar in IBD: A prolonged follow-up on the efficacy and safety across Italy
Year: 2017
Source: ECCO'17 Barcelona
Authors: Fiorino G.
Last Modified: Wednesday, 15 March 2017, 1:53 PM by ECCO Administrator
Anti drug antibodies, Anti-TNF agents, Infliximab, Biosimilars
Files: 1
OP006: Apremilast for active Ulcerative Colitis: A phase 2, randomised, double-blind, placebo-controlled induction study
Year: 2018
Source: ECCO'18 Vienna
Authors: Danese Silvio
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP006: Correlation of durability of response, serum trough concentrations and outcome parameters: Long-term follow-up of the Trough Concentration Adapted Infliximab Treatment (TAXIT) trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Pouillon L.
Last Modified: Wednesday, 15 March 2017, 1:55 PM by ECCO Administrator
Chron's disease, Ulcerative colitis, Anti TNF drug levels, Anti drug antibodies, Infliximab
Files: 1
OP007: A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Lawrance I.
Last Modified: Wednesday, 15 March 2017, 2:21 PM by ECCO Administrator
Tacrolimus, Proctitis
Files: 1
OP007: Detection of mucosal healing with a serum marker panel in adalimumab treated patients with Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: de Bruyn Magali
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP008: An innovative treatment for refractory perianal fistulas in Crohn’s Disease: Local micro reinjection of autologous fat and adipose derived stromal vascular fraction (ClinicalTrials. gov NCT02520843, Eudract: 2013-002602-31)
Year: 2017
Source: ECCO'17 Barcelona
Authors: Serrero M.
Last Modified: Wednesday, 15 March 2017, 2:24 PM by ECCO Administrator
Perenial fistulae, Perianal disease, Autologous stem cell transplantation
Files: 1
OP009: A combination of clinical, serological and genetic factors predicts complicated disease course in paediatric-onset Crohn’s disease: results from a population-based study.
Year: 2018
Source: ECCO'18 Vienna
Authors: Sarter Hélène
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
Year: 2017
Source: ECCO'17 Barcelona
Authors: Panés J.
Last Modified: Wednesday, 15 March 2017, 2:43 PM by ECCO Administrator
Stem cell transplantation/therapy
Files: 1
OP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Last Modified: Wednesday, 15 March 2017, 2:45 PM by ECCO Administrator
Ustekinumab
Files: 1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
Year: 2018
Source: ECCO'18 Vienna
Authors: Al Bakir Ibrahim
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP011:Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Peyrin-Biroulet L.
Last Modified: Wednesday, 15 March 2017, 2:47 PM by ECCO Administrator
Etrolizumab
Files: 1
OP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with Ulcerative Colitis undergoing (procto)colectomy with ileal pouch- anal anastomosis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Ferrante M.
Last Modified: Wednesday, 15 March 2017, 2:49 PM by ECCO Administrator
Ulcerative colitis, Ileo anal pouch procedure, Post operative complications, Post operative medical management, Vedolizumab
Files: 1
OP013: Disease management and outcomes of patients with Crohn’s Disease at high risk of recurrence. Results from PRACTICROHN study
Year: 2017
Source: ECCO'17 Barcelona
Authors: Iborra M.
Last Modified: Wednesday, 15 March 2017, 2:52 PM by ECCO Administrator
Colonscopy, Ileo caecal resection, Post operative complications, Post operative medical management, Thiopurines ( AZA / MP )
Files: 1
OP013: HLA-DQA1 contributes to the development of antibodies to anti-TNF therapy in Crohn's Disease
Year: 2018
Source: ECCO'18 Vienna
Authors: Sazonovs Aleksejs
Created: Friday, 23 March 2018, 12:23 PM
Last Modified: Thursday, 5 July 2018, 10:50 AM by Lindley Fritze
OP014: Analysis of 1792 gut metagenomes reveals microbial treatment targets for Inflammatory Bowel Disease and irritable bowel syndrome
Year: 2018
Source: ECCO'18 Vienna
Authors: Vich Vila Arnau
Created: Friday, 23 March 2018, 12:23 PM
Last Modified: Thursday, 5 July 2018, 10:51 AM by Lindley Fritze
Files: 1
OP014: Histological remission is predictive of improved clinical outcomes in patients with Ulcerative Colitis: Results from the TOUCHSTONE OLE
Year: 2017
Source: ECCO'17 Barcelona
Authors: Feagan B.
Last Modified: Wednesday, 15 March 2017, 2:49 PM by ECCO Administrator
Ozanimod, Histological remission
Files: 1
OP015: Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn’s Disease: THE LIR!C TRIAL
Year: 2017
Source: ECCO'17 Barcelona
Authors: de Groof J.
Last Modified: Wednesday, 15 March 2017, 2:47 PM by ECCO Administrator
Crohn's disease, Ileo caecal resection, Laparoscopic surgery, Infliximab
Files: 1
OP016: Need for primary abdominal surgery, but not repeated surgery, has decreased – a nationwide study of temporal trends in Crohn surgery in Sweden 1990-2014
Year: 2018
Source: ECCO'18 Vienna
Authors: Kalman Disa
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
OP016: Potential role of bile acid receptor FXR in microscopic colitis
Year: 2017
Source: ECCO'17 Barcelona
Authors: Palmela C.
Last Modified: Wednesday, 15 March 2017, 2:17 PM by Vesna Babaja
Histology, Microscopic colitis
Files: 1